ZBC has partnered with Dr. Larry Kushi at the Kaiser Permanente Northern California Division of Research for more than a decade. The Pathways Study seeks "to provide more objective information to help guide women as they make decisions following a breast cancer diagnosis by collecting and analyzing data about a woman's genetic background, tumor characteristics and lifestyle choices immediately after diagnosis. It also studies various genetic factors and their role in treatment and survival as well as whether certain molecular changes in the tumor may be markers for prognosis.
Check out ZBC's Survivorship Factsheets, created in collaboration with Pathways scientists and breast cancer survivors.
Learn more about the Pathways study.